Preface |
Introduction / Part 1: |
From life sciences to organization sociology / 1: |
What the book is not about! / 1.0: |
An overview of the studies on the biotechnology industry / 1.1: |
The constitution of a new technological field / 1.2: |
The research method / 1.3: |
Outline of the book / 1.4: |
The history of the biotechnology industry / 2: |
The conceptual struggle / 2.0: |
The research field of biological engineering - an enabling technology / 2.2: |
The industrial application of new biotechnologies / 2.3: |
The development of competencies - cross-fertilizing of processes and techniques / 2.4: |
Network formation and resource dependency / 2.5: |
Construction / Part II: |
The biotechnology community / 3: |
The theoretical aspects of the systems approach / 3.0: |
The biotechnology community - introduction of the actors / 3.2: |
Strategies among biotechnology firms / 3.3: |
The role of universities - from knowledge generators to profit makers / 3.4: |
Technology parks - incubators of biotechnology / 3.5: |
Public regulatory bodies - a balance between restriction, approval and promotion. 3.7 Venture capital - the noble art of balancing between altruism and cannibalism / 3.6: |
Pharmaceutical and chemical firms - the late adopters / 3.8: |
Summary / 3.9: |
Reconstruction / Part III: |
Theoretical aspects of strategies and networks / 4: |
An organizational perspective on strategies and networks - shifting the level of analysis / 4.0: |
The organization of technological search and learning / 4.1: |
The internal organization - dominating coalitions and the formation of routines / 4.2: |
Firms in networks - the external relations / 4.3: |
Networking activities - types and backgrounds / 4.4: |
Strategic behavior and the formation of networks - a summary / 4.5: |
The co-evolution of strategies and networks - designing the case studies / 5: |
The parallel and intertwined processes of network formation / 5.0: |
Designing the case studies of the three types of strategies / 5.2: |
The conceptualization of the empirical field / 5.3: |
On the track - what next? / 5.4: |
The project strategy / Part IV: |
The history of the firm / 6.0: |
Phase I: Kem-En-Tec 1983-1993 / 6.2: |
Phase II Establishing subsidiaries / 6.3: |
The future of Kem-En-Tec - the problem of the project strategy / 6.4: |
The new future of an experimenting firm - the 2001 update / 6.5: |
Conclusion - the project strategy a question of "exits" / 6.6: |
The incremental strategy / 7: |
AndCare, Inc. / 7.0: |
ThermoGen Inc. / 7.2: |
Conclusion on the incremental strategy / 7.3: |
The vertical integration strategy / 8: |
Calgene, Inc. / 8.0: |
Incyte Genomics, Inc. / 8.2: |
Conclusion of the vertical integration strategy / 8.3: |
Conclusion / Part V: |
The role of the biotechnological industries / 9: |
From industrial sociology to organizational sociology / 9.0: |
Strategy and networks - a mating dance / 9.2: |
The entrepreneurial strategies revisited / 9.3: |
The managerial aspects of the network processes / 9.4: |
The neo-schumpeterian strategies / 9.5: |
The constitution of technological fields / 10: |
The theoretical ambition of the study revisited / 10.0: |
The embeddedness of routines, communities of practice, and technological systems / 10.1: |
The role of organizational routines / 10.2: |
The role of communities of practice / 10.3: |
The role of technological systems / 10.4: |
Four entrepreneurial abilities in the constitution of technological fields / 10.5: |
References |
List of interviews |
Preface |
Introduction / Part 1: |
From life sciences to organization sociology / 1: |